Positive impactStocks
These 15 midcap stocks soared up to 98% in a year; check FII and MF holdings
Economic Times 1 hr ago·29 Jul 2026, 9:29 am
Laurus Labs has been a standout performer in the midcap space, delivering a massive return of nearly 98% over the past year. This rally has made it one of the most valuable companies in its category, significantly outpacing the broader market's sluggish performance. Such a sharp surge in valuation has naturally attracted significant attention from both domestic and international investors.
The stock's meteoric rise is closely tied to the company's strong execution in its core pharmaceutical business. Investors are closely watching the company's ability to sustain this growth momentum and manage its expansion plans. A key area of focus for traders will be the changes in Foreign Institutional Investor (FII) and Mutual Fund (MF) holding patterns, as these flows often signal the next phase of price action for the stock.
Excerpt from Economic Times
While the Nifty50 has declined about 3% over the past year, the Nifty Midcap 150 has delivered a modest gain of nearly 8%. But the real story lies beneath the surface. Several midcap stocks have significantly outperformed the broader index, posting remarkable gains during the same period. As many as 31 midcap stocks…Read the original at Economic Times
Affected stocks
Bullish2 stocks
Bull / bear label is derived from the article's AI sentiment — indicative, not advice. Prices may be delayed.
Key takeaways
- Concerns Laurus Labs (LAURUSLABS).
- Category: Stocks.
- AI reads the tone as positive (potentially bullish) for the stock.
- Also mentions BHARATFORG.
Why it matters
A routine update for Laurus Labs. The tone is positive — historically associated with upward pressure, though not predictive. Use the price and stock snapshot to gauge how the market is responding.
